Express News | The opening of the tenth batch of national Pharmaceutical centralized purchasing has prompted nearly 30 listed companies to announce their products are likely to be selected after the market close.

BreakingsDec 13 21:24

Express News | Zhejiang Tianyu Pharmaceutical: Two products of the subsidiary are proposed to be selected for the tenth batch of national Pharmaceutical procurement.

BreakingsDec 13 17:08

TF Securities Starts Zhejiang Tianyu Pharmaceutical at Buy With 22.83 Yuan Price Target

MT NewswiresDec 13 15:33 · Ratings

Zhejiang Tianyu Pharmaceutical (300702): Accelerated growth of non-sartan Active Pharmaceutical Ingredient, collaborative development of CDMO and formulation.

Zhejiang Tianyu Pharmaceutical was established in 2003, specializing in the research and development, manufacturing, and sales of Active Pharmaceutical Ingredients and advanced pharmaceutical intermediates. It is a leading supplier of cardiovascular Active Pharmaceutical Ingredients globally and a core domestic supplier of the oral COVID-19 drug Molnupiravir intermediates for Merck in the USA.

TianfengDec 13 13:17

Express News | Institutions are bullish on these stocks today.

BreakingsNov 28 21:44

gf sec: The upstream prices of penicillin and cephalosporin are fluctuating at high levels, while the active pharmaceutical ingredient is stabilizing at a low point.

According to data from the National Bureau of Statistics, the year-on-year PPI value for the manufacturing of active pharmaceutical ingredients in September 2024 is 97.10, an increase of 2.0 compared to the previous month, and up 1.63 from the average of 95.47 in the first half of 2024. Since the year-on-year PPI for active pharmaceutical ingredient manufacturing fell below 100 in the entire year of 2023, the recent PPI values have been on the rise, indicating that the overall price of active pharmaceutical ingredients is in a slight recovery phase after reaching a low.

Zhitong FinanceNov 20 14:42